PI3Kδ-IN-2

CAS No. 1702816-75-8

PI3Kδ-IN-2( —— )

Catalog No. M20551 CAS No. 1702816-75-8

PI3Kδ-IN-2 is a potent and selective inhibitor of PI3Kδ .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 36 In Stock
5MG 58 In Stock
10MG 87 In Stock
25MG 192 In Stock
50MG 295 In Stock
100MG 462 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PI3Kδ-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    PI3Kδ-IN-2 is a potent and selective inhibitor of PI3Kδ .
  • Description
    PI3Kδ-IN-2 is a potent and selective inhibitor of PI3Kδ.(In Vitro):Linperlisib (YY-20394) is under the study for the recurrent and/or refractory follicular lymphoma.
  • In Vitro
    Linperlisib (YY-20394) is under the study for the recurrent and/or refractory follicular lymphoma.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    PI3Kδ
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1702816-75-8
  • Formula Weight
    588.69
  • Molecular Formula
    C28H37FN6O5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:25 mg/mL (42.47 mM)
  • SMILES
    COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)C(C)(C)O)cc(F)cc12)N1CCOCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • MOMIPP

    MOMIPP is a PIKfyve inhibitor and a macropinocytosis inducer. MOMIPP readily penetrates the blood-brain barrier and is moderately effective in suppressing progression of intracerebral glioblastoma xenografts.

  • PI-828

    PI-828 is a phosphatidylinositol 3-kinase (PI3K) inhibitor, which is widely used to study the physiological function of PI3K and also promotes stem cell differentiation into mesoderm.

  • I-OMe-Tyrphostin AG ...

    I-OMe-Tyrphostin AG 538 is a specific IGF-1R inhibitor and ATP-competitive inhibitor of PI5P4Kα (IC50: 1 μM).